Mitessh Thakkar: BUY TCS, Dr Lal Pathlabs; SELL IRCTC and Sun Pharma
Market analyst Mitesh Thakkar has suggested two BUY Calls and two SELL Calls for today’s trading session. Indian markets are expected to open flat but we can expect recovery in the markets. Asian markets were trading positive today, after last week’s selloff due to COVID strain Omicron. US markets closed positive on Monday.
Thakkar has suggested BUY Call for Dr Lal Pathlabs for a target of Rs 3,970 with a stop loss at Rs 3,840. Traders can initiate a BUY Trade for technology major TCS for a target of Rs 3,550 with a stop loss at Rs 3,480, as per Thakkar.
Thakkar has suggested SELL trade for railways catering company IRCTC for a target of Rs 740 with a stop loss at Rs 802. Thakkar has suggested SELL CALL for pharmaceutical major Sun Pharma for a target of Rs 725 with a stop loss at Rs 758.
All trades should be carried out with strict Stop Loss. In case the trade doesn’t happen as per expectations, it is good to exit the trade if the call is in profit. TopNews will review performance of trading calls by the end of the trading session.